Gujarat Themis Biosyn

Gujarat Themis Biosyn is an India-based pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) through fermentation technology. Established as a joint venture, the company is a leading producer of Rifamycin S, an essential intermediate for the anti-tuberculosis drug Rifampicin, and Rifamycin O. It operates a state-of-the-art manufacturing facility in Vapi, Gujarat, and has expanded its capabilities into contract manufacturing and development services (CDMO). The company's focus on niche fermentation-based products positions it as a key player in the global supply chain for critical antibiotics and other therapeutic classes.